HD-OPM Archive
Hashtags

#aspirin

31 posts

Berberine lowered plaque score 3.2% and TMAO in a small 21-patient trial

Jun 10, 2024 · Louis Nervegna ♥ 18 · 💬 23 Gut microbiome

Louis highlights a small human trial in which berberine reduced atherosclerotic plaque score, with a proposed mechanism of lowering gut-derived TMAO by acting on TMAO-producing gut bacteria. The sample is small and the comparison group was not randomized to the same degree as a large trial, so this is hypothesis-generating.

Heart attack clots form on ruptured unstable plaque, not in plaque-free arteries

Mar 17, 2025 · Louis Nervegna ♥ 29 · 💬 12 Heart attack, stroke & procedures

Louis argues that although most heart attacks are caused by clots, clots form when unstable plaque ruptures, so people with near-zero plaque have near-zero risk of clot-caused heart attacks. Blood thinners like aspirin are proven to lower risk in people with considerable plaque but are unlikely to help, and may harm, those with little or no plaque.

Baby aspirin may be worth considering for people with high Lp(a)

Jul 13, 2025 · Louis Nervegna ♥ 25 · 💬 13 Lp(a)

Louis suggests low-dose aspirin is worth considering in people with elevated Lp(a), linking a physician's post and a 2025 review on the aspirin prevention conundrum. The referenced material argues Lp(a) may redefine aspirin's role in primary prevention.

SCOT-HEART: CT angiography cut 5-year coronary death or MI risk 41% in chest pain patients

Jan 03, 2026 · Gokhan Can ♥ 12 · 💬 18 Plaque, CAC & CT angiography

Summarises SCOT-HEART (4,146 patients with stable chest pain, standard care vs standard care plus coronary CTA). CTA guidance lowered coronary death or nonfatal MI to 2.3% from 3.9%, mainly by directing aspirin and statin use to patients with plaque. Total procedures were similar by year 5; results apply to chest-pain patients only.

Heart attacks peak in the early morning; bedtime dosing of BP drugs may help

Jun 27, 2026 · Louis Nervegna ♥ 14 · 💬 14 Heart attack, stroke & procedures

Louis explains that most heart attacks occur shortly after waking, when cortisol surges, vessels tighten and blood pressure spikes. He suggests taking blood pressure medication, aspirin and statins at bedtime, and corrects his post to say people are found dead in the 'bathroom' rather than 'toilet', since defecation syncope is much rarer than a standard heart attack.

Baby aspirin during and after Covid may be worth discussing if you have heart disease

Jan 06, 2024 · Louis Nervegna ♥ 14 · 💬 12 Infections & vaccines

Louis suggests people with heart disease who get Covid ask their doctor about baby aspirin during infection and for a few weeks after. Infections temporarily raise heart attack and stroke risk through inflammation, and Covid raises clot risk more than other infections. A linked 2022 meta-analysis found aspirin use associated with lower Covid mortality without more bleeding.

Platelet reactivity score (PRESS) predicts cardiovascular events in PAD patients

Aug 20, 2024 · Gokhan Can ♥ 6 · 💬 19 Aspirin, antiplatelets & blood thinners

NYU researchers developed PRESS, combining platelet aggregation responses and RNA sequencing, to detect platelet hyperreactivity. In PAD patients, hyperreactive platelets predicted more major adverse cardiac or limb events within 30 days of revascularization, and PRESS above the median carried a 90% higher risk of major events over 18 months. It might help target aspirin.

Flu and respiratory infections raise heart attack risk; ask your doctor about baby aspirin

Sep 11, 2024 · Louis Nervegna ♥ 13 · 💬 8 Infections & vaccines

Louis shares MedPage Today coverage of another study confirming that infections like flu temporarily raise heart attack and stroke risk. He suggests that people with CVD ask their doctor about daily baby aspirin during illness and for a period afterward. The proposed mechanism is increased metabolic demand plus inflammatory and coagulation effects that destabilize plaque.

Aspirin blocks platelet TXA2 suppression of T cells and reduces metastasis in mice

Dec 07, 2025 · Louis Nervegna ♥ 18 · 💬 4 Aspirin, antiplatelets & blood thinners

Louis shares a 2025 Nature study showing that platelet-derived thromboxane A2 binds CD8+ T cells and, via ARHGEF1, weakens their anti-tumor activity. Aspirin or COX-1 inhibitors lifted this and reduced metastatic burden in mouse melanoma and lung models, only in animals with intact T-cell immunity, suggesting a mechanism for aspirin's apparent cancer protection.

ASPREE: aspirin tied to 70% lower dementia with high platelet-count genetic scores

Oct 02, 2026 · Louis Nervegna ♥ 10 · 💬 4 Aspirin, antiplatelets & blood thinners

Monash researchers analysed genetic data from 13,541 ASPREE participants and found that among those in the top 20% of a platelet-count polygenic score, 1% on 100 mg aspirin developed dementia versus 3.3% on placebo. Aspirin is not recommended for dementia prevention, and this is a genetic subgroup finding that needs confirmation, with bleeding risk to weigh.

One zoledronate infusion cut vertebral fractures about 44% over 10 years in women 50-60

Jan 18, 2025 · Gokhan Can ♥ 4 · 💬 9 Hormones, women's & men's health

Gokhan shares the NEJM 10-year randomized trial of infrequent zoledronate in early postmenopausal women (50-60 years) with normal-to-low-normal bone density. Zoledronate roughly halved new morphometric vertebral fractures versus placebo, and he calls it a longevity-type drug like statins or aspirin. The trial concerns bone rather than heart outcomes.

Infections temporarily raise heart attack and stroke risk; vaccines may do so far less

Oct 14, 2024 · Louis Nervegna ♥ 12 Infections & vaccines

Louis explains that infections such as flu raise short-term heart attack and stroke risk through inflammation and coagulation effects that destabilize plaque, and that the effect fades in a week or two. Vaccines can in theory do this to a much smaller degree. He suggests asking a doctor about a baby aspirin during and shortly after infection, and avoiding hs-CRP tests during that window.

CHIP not tied to heart attack or stroke in a 9,434-person aspirin trial, but to bleeding

Oct 18, 2025 · Louis Nervegna ♥ 1 · 💬 1 Aspirin, antiplatelets & blood thinners

Louis shares a JAMA Cardiology secondary analysis of a primary-prevention aspirin trial (9,434 participants) on clonal hematopoiesis of indeterminate potential (CHIP), a common aging-related blood cell mutation. CHIP was not associated with more cardiovascular events but was associated with more clinically significant bleeding, and aspirin's effects did not differ by CHIP status. He also explains what CHIP is.

ASPREE sub-analysis: aspirin tied to ~70% lower dementia in a platelet-genetics subgroup

Oct 05, 2026 · Louis Nervegna ♥ 1 Aspirin, antiplatelets & blood thinners

A genetic analysis of 13,541 ASPREE participants found aspirin did not prevent dementia overall, but in the top 20% of a platelet-count genetic score dementia occurred in about 1% on aspirin versus 3.3% on placebo. Major bleeding was more than twice as common in this subgroup, so the post cautions against starting aspirin for dementia prevention.